Suppr超能文献

黄斑病变患者视力的矛盾性改善。

Paradoxical improvement of visual acuity in macular disease.

机构信息

Department of Ophthalmology, Asahikawa Medical College, Japan.

出版信息

Curr Eye Res. 2010 Jul;35(7):651-6. doi: 10.3109/02713681003707235.

Abstract

PURPOSE

Improvement in visual acuity is often considered the best indicator of the effectiveness of a treatment in age-related maculopathy. However, during the course of the disease, the location of the patients' preferred retinal locus of fixation may change. This can lead to an unexpected functional improvement, unrelated to treatment.

METHODS

From a running database of 1,369 retina patients, we identified 116 patients over 60 years of age when age-related maculopathy was diagnosed based on the following inclusion criteria: one study eye with an initial acuity of the logarithm of the minimum angle of resolution (logMAR) 0.7 or worse, a fellow eye with central fixation and a follow-up period of 3 years or more with precise documentation of the preferred retinal locus of fixation and scotoma distribution for both eyes using scanning laser ophthalmoscopy-based microperimetry.

RESULTS

We expected an improvement in the visual acuity in one eye (study eye) without the possibility of improvement due to previous or concurrent treatment in that eye. Twelve patients met the selection criteria. Over time, these patients had significant improvements in the visual acuity in the weaker study eye, characteristically accompanied by a concurrent decrease in visual acuity in the other eye, which initially had better visual acuity. Moreover, in all the study eyes, an unstable pseudo-central von Noorden fixation pattern evolved into a more stable eccentric preferred retinal locus.

CONCLUSIONS

Visual acuity remains the gold standard for assessing visual functioning in age-related maculopathy when interpreted with caution. Improvements in visual acuity can occur solely due to the course of the disease in the other eye and as a result of its impact on binocular fixation characteristics. This finding has significant implications for low-vision rehabilitation and evaluation of various therapies in large long-term clinical studies.

摘要

目的

视力的提高通常被认为是年龄相关性黄斑病变治疗效果的最佳指标。然而,在疾病过程中,患者的最佳视网膜固视点位置可能会发生变化。这可能导致与治疗无关的意外功能改善。

方法

从一个运行中的 1369 例视网膜患者数据库中,我们确定了 116 名 60 岁以上的患者,这些患者符合以下纳入标准:一眼有初始视力对数最小角分辨率(logMAR)为 0.7 或更差,另一眼有中心固视,随访时间为 3 年或更长时间,并且使用基于扫描激光检眼镜的微视野计精确记录了双眼的最佳视网膜固视点位置和暗点分布。

结果

我们预计一只眼(研究眼)的视力会提高,而该眼以前或同时进行的治疗不可能导致视力提高。符合选择标准的有 12 名患者。随着时间的推移,这些患者在较弱的研究眼中的视力显著提高,同时另一只初始视力较好的眼睛的视力也相应下降。此外,在所有研究眼中,不稳定的假性中央冯·诺登固视模式演变为更稳定的偏心最佳视网膜固视点。

结论

在谨慎解读的情况下,视力仍然是评估年龄相关性黄斑病变视觉功能的金标准。视力的提高可能仅仅是由于另一只眼疾病的发展,以及其对双眼固视特征的影响所致。这一发现对低视力康复和各种疗法在大型长期临床研究中的评估具有重要意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验